# Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways

> **NCT04349293** · NA · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 150 (estimated)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Tissue sampling
- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT04349293
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09-08
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349293, "Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04349293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*